Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | r2r3-MYB transcription factor, putative | 0.0009 | 1 | 1 |
Entamoeba histolytica | myb-like DNA-binding domain containing protein | 0.0009 | 0 | 0.5 |
Giardia lamblia | Myb 1-like protein | 0.0009 | 0.9635 | 0.5 |
Toxoplasma gondii | Myb family DNA-binding domain-containing protein | 0.0009 | 0.9635 | 0.5 |
Entamoeba histolytica | myb-like DNA-binding domain containing protein | 0.0009 | 0 | 0.5 |
Entamoeba histolytica | myb-like DNA-binding domain containing protein | 0.0009 | 0 | 0.5 |
Trichomonas vaginalis | MYB, putative | 0.0009 | 1 | 1 |
Entamoeba histolytica | myb-like DNA-binding domain containing protein | 0.0009 | 0 | 0.5 |
Entamoeba histolytica | myb-like DNA-binding domain containing protein | 0.0009 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.